IDH1 and astrocytoma (excluding glioblastoma): It is well known that IDH mutational status is associated with patient overall survival [30]; due to this fact, to evaluate the Patient Survival Score’s true potential to predict astrocytoma patients’ survival, it is essential to test how IDH1 mutational status alone can predict it.